As of February 2022, mRNA-based vaccine Comirnaty, developed by Pfizer/Biontech, was the leading COVID-19 vaccine by efficacy rate, showing around 95 percent of efficacy against COVID-19. This statistic illustrates the comparison of select COVID-19 vaccines worldwide, by efficacy.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Evaluate Vantage. (February 23, 2022). Comparison of select COVID-19 vaccines worldwide as of 2022, by efficacy [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1301122/covid-vaccines-comparison-by-efficacy/
Evaluate Vantage. "Comparison of select COVID-19 vaccines worldwide as of 2022, by efficacy." Chart. February 23, 2022. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1301122/covid-vaccines-comparison-by-efficacy/
Evaluate Vantage. (2022). Comparison of select COVID-19 vaccines worldwide as of 2022, by efficacy. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1301122/covid-vaccines-comparison-by-efficacy/
Evaluate Vantage. "Comparison of Select Covid-19 Vaccines Worldwide as of 2022, by Efficacy." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Feb 2022, /statistics/1301122/covid-vaccines-comparison-by-efficacy/
Evaluate Vantage, Comparison of select COVID-19 vaccines worldwide as of 2022, by efficacy ÌÇÐÄÆƽâ°æ, /statistics/1301122/covid-vaccines-comparison-by-efficacy/ (last visited July 20, 2026)
Comparison of select COVID-19 vaccines worldwide as of 2022, by efficacy [Graph], Evaluate Vantage, February 23, 2022. [Online]. Available: /statistics/1301122/covid-vaccines-comparison-by-efficacy/
